Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.6B | 10.0B | 11.8B | 11.4B |
Cost of revenue | 7.5B | 7.8B | 8.7B | 8.9B |
Gross profit | 2.2B | 2.2B | 3.0B | 2.5B |
Operating expense | ||||
Research & development | 131.6M | 149.1M | 165.2M | 154.9M |
Selling general and admin | 1.1B | 1.1B | 1.1B | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | 935.7M | 1.0B | 1.8B | 1.3B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 603.5M | 550.5M | 600.5M | 574.0M |
Other income expense | — | — | — | — |
Pretax income | -246.5M | 825.4M | 806.8M | 787.7M |
Tax provision | -67.9M | 147.8M | 222.4M | 104.9M |
Net income | -178.7M | 677.6M | 584.4M | 682.7M |
Basic EPS | -0.1 | 0.3 | — | 0.3 |
Diluted EPS | -0.1 | 0.3 | — | 0.3 |
Basic average shares | 1.5B | 1.6B | — | 1.6B |
Diluted average shares | 1.5B | 1.6B | — | 1.6B |
EBITDA | 911.6M | 1.9B | 2.6B | 1.9B |
Net income from continuing op. | -246.5M | 825.4M | 806.8M | 787.7M |
Minority interests | 70.4M | -280.7M | -219.2M | -137.9M |
Preferred stock dividends | 0 | 0 | 0 | 0 |